DD vs JNJ · P/E 127, rev $3.50B vs P/E 17, rev $49.37B
Dupont De Nemours Inc (DD) versus Johnson & Johnson (JNJ) — a side-by-side from cached financials, not a winner call.
Dupont De Nemours Inc (DD) is a specialty chemicals company listed on US.
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
Latest reported DD revenue for 2026-06-30 was $3.50B. Net income was $304.0M. DD currently screens at market cap $19.61B and trailing P/E 127.4.
Latest reported JNJ revenue for 2026-06-28 was $49.37B. Net income was $10.77B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
DD currently screens at market cap $19.61B and trailing P/E 127.4. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
Not investment advice. Open the DD and JNJ stock pages for the full models.
Not investment advice.